Table 2.
Comparison of gastric cancer risk factors between training group and testing group
| Variables | n=283 | Training group (n=211) | Test group (n=72) | p-value |
|---|---|---|---|---|
| Gender | 0.641 | |||
| Female | 88 | 64 | 24 | |
| Male(BL) | 195 | 147 | 48 | |
| Type of histopathology | 0.392 | |||
| Adenocarcinoma | 229 | 166 | 63 | |
| Others | 10 | 6 | 4 | |
| Grade | 0.425 | |||
| Weak | 26 | 21 | 5 | |
| Middle or good(BL) | 115 | 84 | 31 | |
| Advanced stage of disease | 0.63 | |||
| Initial stage | 49 | 34 | 15 | |
| Local metastasis | 52 | 39 | 13 | |
| Distant metastasis | 101 | 78 | 23 | |
| Distant metastasis | 0.467 | |||
| Yes | 118 | 88 | 30 | |
| No | 62 | 50 | 12 | |
| Metastasis organ | 0.944 | |||
| Liver | 74 | 55 | 19 | |
| Others | 44 | 33 | 11 | |
| Type of treatment | 0.618 | |||
| Treatment1 | 180 | 136 | 44 | |
| Treatment2 | 18 | 11 | 7 | |
| Treatment3 | 61 | 46 | 15 | |
| Treatment4 | 24 | 18 | 6 | |
| Age of diagnosis | 0.177 | |||
| 70> | 165 | 118 | 47 | |
| ≥ 70 | 118 | 93 | 25 | |
| Status | 0.982 | |||
| Death | 208 | 155 | 53 | |
| Censor | 75 | 56 | 19 |